Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Simonneau

Showing results (211-220 of 240) with videos related to

Pageof 24
Sort By:
Nature Medicine|September 24, 2002
Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertensionJ-M Launay, P Hervé, K Peoc'h, et al.
The New England Journal of Medicine|August 29, 1996
Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study GroupL Abenhaim, Y Moride, F Brenot, et al.
The American Review of Respiratory Disease|June 1, 1992
Lack of bronchial hyperresponsiveness to methacholine and to isocapnic dry air hyperventilation in heart/lung and double-lung transplant recipients with normal lung histology. The Paris-Sud Lung Transplant GroupP Herve, N Picard, M Le Roy Ladurie, et al.
Revue Des Maladies Respiratoires|March 5, 2018
[Pulmonary veno-occlusive disease]A Boucly, B Girerd, D Bourlier, et al.
Thorax|August 2, 2005
Survival in patients with class III idiopathic pulmonary arterial hypertension treated with first line oral bosentan compared with an historical cohort of patients started on intravenous epoprostenolO Sitbon, V V McLaughlin, D B Badesch, et al.
The European Respiratory Journal|September 11, 2004
Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2M Humbert, R J Barst, I M Robbins, et al.
The New England Journal of Medicine|February 12, 1998
A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prévention du Risque d'Embolie Pulmonaire par Interruption Cave Study GroupH Decousus, A Leizorovicz, F Parent, et al.
Respiratory Medicine and Research|September 27, 2019
Klippel-Trenaunay syndrome as a rare cause of chronic thromboemboembolic pulmonary hypertensionA Seferian, X Jaïs, L Savale, et al.
Transplantation|June 27, 1996
Intrapulmonary production of RANTES during rejection and CMV pneumonitis after lung transplantationG Monti, A Magnan, M Fattal, et al.
The European Respiratory Journal|June 23, 2009
Cautious epoprostenol therapy is a safe bridge to lung transplantation in pulmonary veno-occlusive diseaseD Montani, X Jaïs, L C Price, et al.
Pageof 24

Showing results (211-220 of 240) with videos related to

Sort By:
Pageof 24
Nature Medicine|September 24, 2002
Function of the serotonin 5-hydroxytryptamine 2B receptor in pulmonary hypertensionJ-M Launay, P Hervé, K Peoc'h, et al.
The New England Journal of Medicine|August 29, 1996
Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study GroupL Abenhaim, Y Moride, F Brenot, et al.
The American Review of Respiratory Disease|June 1, 1992
Lack of bronchial hyperresponsiveness to methacholine and to isocapnic dry air hyperventilation in heart/lung and double-lung transplant recipients with normal lung histology. The Paris-Sud Lung Transplant GroupP Herve, N Picard, M Le Roy Ladurie, et al.
Revue Des Maladies Respiratoires|March 5, 2018
[Pulmonary veno-occlusive disease]A Boucly, B Girerd, D Bourlier, et al.
Thorax|August 2, 2005
Survival in patients with class III idiopathic pulmonary arterial hypertension treated with first line oral bosentan compared with an historical cohort of patients started on intravenous epoprostenolO Sitbon, V V McLaughlin, D B Badesch, et al.
The European Respiratory Journal|September 11, 2004
Combination of bosentan with epoprostenol in pulmonary arterial hypertension: BREATHE-2M Humbert, R J Barst, I M Robbins, et al.
The New England Journal of Medicine|February 12, 1998
A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prévention du Risque d'Embolie Pulmonaire par Interruption Cave Study GroupH Decousus, A Leizorovicz, F Parent, et al.
Respiratory Medicine and Research|September 27, 2019
Klippel-Trenaunay syndrome as a rare cause of chronic thromboemboembolic pulmonary hypertensionA Seferian, X Jaïs, L Savale, et al.
Transplantation|June 27, 1996
Intrapulmonary production of RANTES during rejection and CMV pneumonitis after lung transplantationG Monti, A Magnan, M Fattal, et al.
The European Respiratory Journal|June 23, 2009
Cautious epoprostenol therapy is a safe bridge to lung transplantation in pulmonary veno-occlusive diseaseD Montani, X Jaïs, L C Price, et al.
Pageof 24